Portfolio of Stem Cell Stocks
Here is a table of 9 stem cell stocks.
| 9 Stem Cell Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Athersys | ATHX | |
| Brainstorm Cell Therapeutics | BCLI | |
| Geron | GERN | |
| Pluri | PLUR | |
| Sangamo Therapeutics | SGMO | |
| Seneca Biopharma | SNCA | |
| ThermoGenesis | THMO | |
| Vericel | VCEL | |
| VistaGen Therapeutics | VTGN | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
| 9 Stem Cell Stocks | ||
|---|---|---|
Name | Symbol | Last Close |
| Athersys | ATHX | $2.19 |
| Brainstorm Cell Therapeutics | BCLI | $4.42 |
| Geron | GERN | $2.37 |
| Pluri | PLUR | $0.75 |
| Sangamo Therapeutics | SGMO | $4.78 |
| Seneca Biopharma | SNCA | $0.10 |
| ThermoGenesis | THMO | $0.25 |
| Vericel | VCEL | $22.83 |
| VistaGen Therapeutics | VTGN | $0.16 |
Portfolio Values
To inspect the performance of the Stem Cell Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 9 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,111.11 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.The current value of the $10,000 investment is $8,648. The percent return is -13.52%. The annualized return is -2.86%.
| 9 Stem Cell Stocks Returns | ||
|---|---|---|
Name | Symbol | Monthly Returns & Details |
| Athersys | ATHX | -95.24% |
| Brainstorm Cell Therapeutics | BCLI | 3.51% |
| Geron | GERN | 5.33% |
| Pluri | PLUR | -95.42% |
| Sangamo Therapeutics | SGMO | -61.45% |
| Seneca Biopharma | SNCA | -99.93% |
| ThermoGenesis | THMO | -99.37% |
| Vericel | VCEL | 401.76% |
| VistaGen Therapeutics | VTGN | -80.89% |
Portfolio Value Chart for Last 100 Daily Closes
Related Portfolios
Portfolio of Gene Editing (CRISPR) Stocks